motesanib diphosphate: Clinical Trials

10 trials of motesanib diphosphate, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed, 4 terminated, 1 withdrawn. 10 Phase 2, 2 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 210Completed 5, Terminated 4, Withdrawn 1
Phase 12Completed 1, Withdrawn 1

Follow motesanib diphosphate: new trials by email Literature Review of motesanib diphosphate trials Research Report on motesanib diphosphate

Trials (filtered) newest first · largest first

All 10 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Investigational Drug in Combination With Two Chemotherapy Drugs in Women With Locally Recurrent or Metastatic Breast Cancer
Ixabepilone, Capecitabine, Motesanib - Breast Cancer, Metastatic Breast Cancer
Phase 1 / Phase 2WithdrawnSidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University2013-12-012025-05-02
AMG 706 and Octreotide in Treating Patients With Low-Grade Neuroendocrine Tumors
AMG 706, octreotide - Gastrointestinal Carcinoid Tumor, Islet Cell Tumor
Phase 2CompletedEastern Cooperative Oncology Group462008-11-072023-07-05
AMG 706 in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
motesanib diphosphate - Fallopian Tube Cancer, Ovarian Cancer
Phase 2TerminatedGynecologic Oncology Group232007-12-012018-01-11
A Phase 2 Trial of AMG 706 or Bevacizumab in Combination With Chemo for Advanced NSCLC
Bevacizumab, AMG 706, Paclitaxel - Advanced Non-squamous NSCLC
Phase 2TerminatedAmgen1862007-01-312018-01-04
A Study of AMG 706 or Bevacizumab, in Combination With Paclitaxel Chemotherapy, as Treatment for Breast Cancer
AMG 706 placebo, Bevacizumab, AMG 706 - Breast Neoplasms, Breast Tumors
Phase 2TerminatedAmgen2822006-12-012015-10-15
An Open Label Treatment Extension Study of AMG 706
AMG 706 - Solid Tumors
Phase 2TerminatedAmgen942005-12-012015-10-15
Evaluate the Efficacy of AMG 706 to Treat Advanced Gastrointestinal Stromal Tumors
AMG 706 - Advanced Gastrointestinal Stromal Tumor
Phase 2CompletedAmgen352005-11-012014-02-27
A Phase 2, Open-label Study of AMG 706 to Treat Subjects With Locally Advanced or Metastatic Thyroid Cancer
AMG 706 - Thyroid Cancer
Phase 2CompletedAmgen1842005-07-012013-10-09
Study to Evaluate Motesanib With or Without Carboplatin/Paclitaxel or Panitumumab in the Treatment of Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)
Panitumumab, Motesanib diphosphate, Paclitaxel - Lung Cancer, Non-Small Cell Lung Cancer
Phase 1 / Phase 2CompletedAmgen512005-01-012016-03-24
Study of AMG 706 in Subjects With Advanced Gastrointestinal Stromal Tumors (GISTs)
AMG 706 - Gastrointestinal Cancer
Phase 2CompletedAmgen1382004-10-012013-04-29

Conditions studied

Breast Neoplasms (2)  ·  Carcinoma, Non-Small-Cell Lung (2)  ·  Adenocarcinoma, Follicular (1)  ·  Adenoma, Islet Cell (1)  ·  Carcinoma, Islet Cell (1)  ·  Carcinoma, Medullary (1)  ·  Carcinoma, Ovarian Epithelial (1)  ·  Fallopian Tube Neoplasms (1)  ·  Gastrinoma (1)  ·  Gastrointestinal Neoplasms (1)  ·  Gastrointestinal Stromal Tumors (1)  ·  Glucagonoma (1)  ·  Insulinoma (1)  ·  Lung Neoplasms (1)  ·  Neoplasms (1)

Sponsors

Amgen (7)  ·  Eastern Cooperative Oncology Group (1)  ·  Gynecologic Oncology Group (1)  ·  Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University (1)

Countries

United States (3)

Top investigators

Edith Mitchell, MD (1)  ·  Mary Mulcahy, MD (1)  ·  Russell J. Schilder, MD (1)

Results publications

PMID 20838998, PMID 18596272, PMID 20739388, PMID 21429799, PMID 25314641, PMID 29853660

NIH funding

U10CA023318 (1)